多发性硬化患者三叉神经痛管理的系统综述
该系统综述检索了Medline、EMBASE和Cochrane数据库(至2016年10月),评估多发性硬化(MS)合并三叉神经痛(TN)患者的药物治疗与手术治疗效果。所有研究按GRADE系统均为低质量;药物治疗证据不足以支持任何一种方案,手术治疗后2年约50%复发,主要并发症为感觉丧失。结论认为早期手术可能更可取,但患者需基于低级别证据决策,从标准药物治疗开始再选择手术。
要点
- 所有纳入研究按GRADE系统均为低质量证据
- 药物治疗证据不足以支持任何一种单一疗法
- 手术治疗后2年约50%患者复发,主要并发症为感觉丧失
核心结论
- 证据不足以支持任何一种药物治疗,因此早期手术可能更可取。
- MS合并TN患者需基于低级别证据做决策,先开始标准药物治疗,再选择一种手术方式。
研究设计与样本
- 系统综述,检索Medline、EMBASE和Cochrane Collaboration数据库,从建库至2016年10月。
- 两名作者独立筛选纳入研究、提取数据和评估偏倚。
- 药物治疗纳入10项研究,其中1项为随机对照试验。
- 手术治疗纳入26项研究,每项至少10例患者且随访至少2年。
主要发现
- 所有研究使用GRADE系统评估均为低质量。
- 药物治疗中,有2项研究关于misopropol的使用,该药为MS患者特有。
- 手术治疗报告了所有类型的手术方式,MS合并TN的手术结果较差,2年时50%复发。
- 主要并发症为感觉丧失。
- 许多患者需接受进一步手术才能无痛,且没有公认的预后因素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 所有研究使用GRADE系统评估均为低质量。
- 证据不足以支持任何一种药物治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Patients with trigeminal neuralgia (TN) and multiple sclerosis (MS) are often treated with medications or a surgical procedure. However, there is little evidence that such treatments result in 50% pain reduction and improvement in quality of life. The aim of this systematic review is to evaluate the clinical effectiveness of treatments in patients with MS and trigeminal neuralgia. METHODS: We searched Medline, EMBASE, and the Cochrane Collaboration database from inception until October 2016. Two authors independently selected studies for inclusions, data extraction, and bias assessment. RESULTS: All studies were of low quality using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. For medical management, 10 studies were included, of which one was a randomized controlled trial. Two studies were on the use of misopropol, unique to patients with MS. For surgical therapy, 26 studies with at least 10 patients and a minimum of 2 years follow-up were included. All types of surgical procedures are reported and the results are poorer for TN with MS, with 50% having a recurrence by 2 years. The main complication was sensory loss. Many patients had to undergo further procedures to become pain free and there were no agreed prognostic factors. CONCLUSIONS: There was insufficient evidence to support any 1 medical therapy and so earlier surgery may be preferable. A patient with TN and MS has therefore to make a decision based on low-level evidence, beginning with standard drug therapy and then choosing a surgical procedure.
引用
- Zakrzewska JM, Wu J, Brathwaite TS, et al. A Systematic Review of the Management of Trigeminal Neuralgia in Patients with Multiple Sclerosis. World Neurosurg. 2017. PMID: 29294398. doi:10.1016/j.wneu.2017.12.147
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。